Pyrazoloisoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them
申请人:LILLY INDUSTRIES LIMITED
公开号:EP0375210B1
公开(公告)日:1995-05-03
US4963558A
申请人:——
公开号:US4963558A
公开(公告)日:1990-10-16
Pyrazolo-[3,4-g]isoquinoline derivatives useful to treat CNS disorders
申请人:Lilly Industries Limited
公开号:US04963558A1
公开(公告)日:1990-10-16
Pharmaceutical compounds of the formula ##STR1## in which R.sup.1 is hydrogen or C.sub.1-6 alkyl, R.sup.2 is hydrogen, C.sub.1-6 alkyl optionally substituted by C.sub.3-9 cycloalkyl or optionally substituted phenyl, C.sub.3-9 cycloalkyl, optionally substituted phenyl, or --SR.sup.4 where R.sup.4 is C.sub.1-6 alkyl optionally substituted by C.sub.3-9 cycloalkyl or optionally substituted phenyl, or C.sub.3-9 cycloalkyl, R.sup.3 is hydrogen, C.sub.1-6 alkyl optionally substituted by C.sub.3-9 cycloalkyl or optionally substituted phenyl, c.sub.3-9 cycloalkyl, or optionally phenyl, and either X and Y are both hydrogen or together are .dbd.O; and acid addition salts thereof. These compounds show useful effects on the central nervous system.